
|Articles|October 1, 2012
Cell-based therapy holds promise for venous leg ulcers
A first-in-class cell-based therapy holds promise for better treatment of chronic venous ulcers. Surprisingly, the less intense regimen - fewer cells, administered less often - proved to be the more effective of the options studied, according to results published online Aug. 2 in The Lancet.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
KT-621 in Atopic Dermatitis: What Early EASI and Pruritus Data Show
2
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
3
Social Media Mythbusters: Skin Cycling
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














